AW

Adam Wilczega

Director Director DIN 05132823
DIN 05132823 First appointment Dec 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Adam Wilczega

Data last updated:

Adam Wilczega has 13 years in corporate governance. Formerly with 1 company, such as M. J. Biopharm Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05132823
Primary Designation Director
First Appointment 10 Dec 2012
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
M. J. Biopharm Private Limited U24234PN2002PTC158855
Additional Director10 Dec 20122002₹367 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
M. J. Biopharm Private Limited
Premium access

Shareholding and investment profile for Adam Wilczega

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adam Wilczega

Adam Wilczega has 13 years in corporate governance. Formerly with 1 company, such as M. J. Biopharm Private Limited. Engaged in General Business. Contributes to corporate operations.

Adam Wilczega is associated with 0 companies as a director.

Adam Wilczega has expertise in General Business.

Adam Wilczega has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available